Pneumocystis jirovecii colonization and infection among non HIV-infected patients

Medecine et Maladies Infectieuses

Volumn 41, Issue 10, 2011, Pages 526-531

  Fily, F ^a   Lachkar, S ^a   Thiberville, L ^a   Favennec, L ^a   Caron, F ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

Colonization; Immunosuppression; Pneumocystis jirovecii; Pneumocystosis; Prolonged corticosteroid therapy

Indexed keywords

ANTINEOPLASTIC AGENT; ATOVAQUONE; CORTICOSTEROID; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; LEFLUNOMIDE; LITHIUM; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUROLEPTIC AGENT; PIPOBROMAN; PREDNISONE; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; ASBESTOSIS; BLOOD DISEASE; CD4 LYMPHOCYTE COUNT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROHN DISEASE; CYSTIC FIBROSIS; DESCRIPTIVE RESEARCH; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FRANCE; FUNGAL COLONIZATION; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFLAMMATORY DISEASE; LONG TERM CARE; LUNG DISEASE; LUNG LAVAGE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORTALITY; MYELOMA; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; OXYGEN THERAPY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTOSIS; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; RESPIRATORY TRACT EXAMINATION; RETROSPECTIVE STUDY; RHEUMATIC FEVER; SOLID TUMOR; SYMPTOMATOLOGY; TEACHING HOSPITAL; TREATMENT DURATION; WELLS SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80054011239     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2011.07.006     Document Type: Article

References (28)

1. Huang L., Morris A., Limper A.H., Beck J.M. ATS pneumocystis workshop participants. An official ATS workshop summary: recent advances and future directions in pneumocystis pneumonia (PCP). Proc Am Thorac Soc 2006, 3:655-664.
2. Takahashi T., Goto M., Endo T., Nakamura T., Yusa N., Sato N., et al. Pneumocystis carinii carriage in immunocompromised patients with and without human immunodeficiency virus infection. J Med Microbiol 2002, 51:611-614.
3. Maskell N.A., Waine D.J., Lindley A., Pepperell J.C., Wakefield A.E., Miller R.F., et al. Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. Thorax 2003, 58:594-597.
4. Morris A., Sciurba F.C., Lebedeva I.P., Githaiga A., Elliott W.M., Hogg J.C., et al. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med 2004, 170:408-413.
5. Vidal S., de la Horra C., Martín J., Montes-Cano M.A., Rodríguez E., Respaldiza N., et al. Pneumocystis jirovecii colonisation in patients with interstitial lung disease. Clin Microbiol Infect 2006, 12:231-235.
6. Limper A.H., Offord K.P., Smith T.F., Martin W.J. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989, 140:1204-1209.
7. Roblot F., Godet C., Le Moal G., Garo B., Souala F., Dary M., et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 2002, 2:523-531.
8. Yale S.H., Limper A.H. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 1996, 71:5-13.
9. Roblot F., Le Moal G., Godet C., Hutin P., Texereau M., Boyer E., et al. Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study. J Infect 2003, 47:19-27.
10. Lyytikäinen O., Ruutu T., Volin L., Lautenschlager I., Jokipii L., Tiittanen L., et al. Late onset of Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1996, 17:1057-1059.
11. Rodriguez M., Fishman J.A. Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus negative immunocompromised patients. Clin Microbiol Rev 2004, 17:770-782.
12. Fishman J.A Prevention of infection caused by Pneumocystis carinii in transplant recipients. Clin Infect Dis 2001, 33:1397-1405.
13. Radisic M., Lattes R., Chapman J.F., del Carmen Rial M., Guardia O., Seu F., et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study. Transpl Infect Dis 2003, 5:84-93.
14. Arend S.M., Westendorp R.G., Kroon F.P., van't Wout J.W., Vandenbroucke J.P., van Es L.A., et al. Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients. Clin Infect Dis 1996, 22:920-925.
15. Godeau B., Coutant-Perronne V., Le Thi Huong D., Guillevin L., Magadur G., De Bandt M., et al. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 1994, 21:246-251.
16. Sepkowitz K.A., Brown A.E., Telzak E.E., Gottlieb S., Armstrong D. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 1992, 267:832-837.
17. Ninin E., Hamidou M., Germaud P., Morin O., Milpied N., Raffi F. Pneumocystose plumonaire chez les patients non VIH. Presse Med 1998, 27:244-249.
18. Overgaard U.M., Helweg-Larsen J. Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002-2004. Scand J Infect Dis 2007, 39:589-595.
19. Amano K. Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy. Intern Med 2006, 45:991-992.
20. Roux N., Flipo R.M., Cortet B., Lafitte J.J., Tonnel A.B., Duquesnoy B., et al. Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases. Rev Rhum Engl Ed 1996, 63:453-456.
21. Yeni P. Prise en charge médicale des personnes infectées par le VIH, recommandations du groupe d'experts. Rapport 2010 2010, La documentation francaise, Paris.
22. Mansharamani N.G., Balachandran D., Vernovsky I., Garland R., Koziel H. Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 2000, 118:712-720.
23. Roblot F. Management of Pneumocystis pneumonia in patients with inflammatory disorders. Expert Rev Anti Infect Ther 2005, 3:435-444.
24. Fishman J.A. Prevention of infection caused by Pneumocystis carinii in transplant recipients. Clin Infect Dis 2001, 33:1397-1405.
25. Nüesch R., Bellini C., Zimmerli W. Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV) positive and HIV negative immunocompromised patients. Clin Infect Dis 1999, 29:1519-1523.
26. Mansharamani N.G., Garland R., Delaney D., Koziel H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995. Chest 2000, 118:704-711.
27. Nevez G., Raccurt C., Vincent P., Jounieaux V., Dei-Cas E. Pulmonary colonization with Pneumocystis carinii in human immunodeficiency virus-negative patients: assessing risk with blood CD4+ T cell counts. Clin Infect Dis 1999, 29:1331-1332.
28. Morris A., Wei K., Afshar K., Huang L. Epidemiology and clinical significance of Pneumocystis colonization. J Infect Dis 2008, 197:10-17.